89 related articles for article (PubMed ID: 11251203)
1. Medial versus lateral parabrachial nucleus lesions in the rat: effects on cholecystokinin- and D-fenfluramine-induced anorexia.
Trifunovic R; Reilly S
Brain Res; 2001 Mar; 894(2):288-96. PubMed ID: 11251203
[TBL] [Abstract][Full Text] [Related]
2. Medial parabrachial nucleus neurons modulate d-fenfluramine-induced anorexia through 5HT2C receptors.
Trifunovic R; Reilly S
Brain Res; 2006 Jan; 1067(1):170-6. PubMed ID: 16343451
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin- and dexfenfluramine-induced anorexia compared using devazepide and c-fos expression in the rat brain.
Li BH; Rowland NE
Regul Pept; 1994 Mar; 50(3):223-33. PubMed ID: 8016407
[TBL] [Abstract][Full Text] [Related]
4. Excitotoxic lesions of the lateral parabrachial nucleus do not prevent cholecystokinin-induced suppression of milk intake in rats.
Trifunovic R; Reilly S
Neurosci Lett; 2003 Sep; 348(2):109-12. PubMed ID: 12902030
[TBL] [Abstract][Full Text] [Related]
5. Reversal of dexfenfluramine-induced anorexia and c-Fos/c-Jun expression by lesion in the lateral parabrachial nucleus.
Li BH; Spector AC; Rowland NE
Brain Res; 1994 Mar; 640(1-2):255-67. PubMed ID: 8004454
[TBL] [Abstract][Full Text] [Related]
6. Effects of vagotomy on cholecystokinin- and dexfenfluramine-induced Fos-like immunoreactivity in the rat brain.
Li BH; Rowland NE
Brain Res Bull; 1995; 37(6):589-93. PubMed ID: 7670882
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to the anorectic effect of dexfenfluramine in rats: role of serotonin, cholecystokinin, and neuropeptide Y.
Rowland NE
Physiol Behav; 1994 Feb; 55(2):201-7. PubMed ID: 8153156
[TBL] [Abstract][Full Text] [Related]
8. Medial versus lateral parabrachial nucleus lesions in the rat: effects on mercaptoacetate-induced feeding and conditioned taste aversion.
Trifunovic R; Reilly S
Brain Res Bull; 2002 May; 58(1):107-13. PubMed ID: 12121820
[TBL] [Abstract][Full Text] [Related]
9. Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329.
Cooper SJ; Dourish CT; Barber DJ
Br J Pharmacol; 1990 Jan; 99(1):65-70. PubMed ID: 2331576
[TBL] [Abstract][Full Text] [Related]
10. Cross tolerance between anorectic action and induction of Fos-ir with dexfenfluramine and 5HT1B/2C agonists in rats.
Rowland NE; Robertson K; Lo J; Rema E
Psychopharmacology (Berl); 2001 Jun; 156(1):108-14. PubMed ID: 11465628
[TBL] [Abstract][Full Text] [Related]
11. Hindbrain noradrenergic lesions attenuate anorexia and alter central cFos expression in rats after gastric viscerosensory stimulation.
Rinaman L
J Neurosci; 2003 Nov; 23(31):10084-92. PubMed ID: 14602823
[TBL] [Abstract][Full Text] [Related]
12. Parabrachial Nucleus Contributions to Glucagon-Like Peptide-1 Receptor Agonist-Induced Hypophagia.
Swick JC; Alhadeff AL; Grill HJ; Urrea P; Lee SM; Roh H; Baird JP
Neuropsychopharmacology; 2015 Jul; 40(8):2001-14. PubMed ID: 25703200
[TBL] [Abstract][Full Text] [Related]
13. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
Currie PJ; Coscina DV; Fletcher PJ
Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586
[TBL] [Abstract][Full Text] [Related]
14. N-methyl-D-aspartate lesions of the lateral hypothalamus do not reduce amphetamine or fenfluramine anorexia but enhance the acquisition of eating in response to tail pinch in the rat.
Clark JM; Clark AJ; Winn P
Psychopharmacology (Berl); 1992; 109(3):331-7. PubMed ID: 1365634
[TBL] [Abstract][Full Text] [Related]
15. Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK.
Becskei C; Grabler V; Edwards GL; Riediger T; Lutz TA
Brain Res; 2007 Aug; 1162():76-84. PubMed ID: 17617389
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding patterns in rats.
Grignaschi G; Mantelli B; Fracasso C; Anelli M; Caccia S; Samanin R
Br J Pharmacol; 1993 Jun; 109(2):491-4. PubMed ID: 8358548
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin-induced anorexia depends on serotoninergic function.
Stallone D; Nicolaïdis S; Gibbs J
Am J Physiol; 1989 May; 256(5 Pt 2):R1138-41. PubMed ID: 2719155
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin and D-fenfluramine inhibit food intake in oxytocin-deficient mice.
Mantella RC; Rinaman L; Vollmer RR; Amico JA
Am J Physiol Regul Integr Comp Physiol; 2003 Nov; 285(5):R1037-45. PubMed ID: 14557235
[TBL] [Abstract][Full Text] [Related]
19. PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement.
Verbaeys I; León-Tamariz F; Buyse J; De Cuyper M; Pottel H; Van Boven M; Cokelaere M
Br J Pharmacol; 2007 Oct; 152(3):396-403. PubMed ID: 17618299
[TBL] [Abstract][Full Text] [Related]
20. The effects of anorectic and aversive agents on deprivation-induced feeding and taste aversion conditioning in rats.
Ervin GN; Birkemo LS; Johnson MF; Conger LK; Mosher JT; Menius JA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1203-10. PubMed ID: 7791092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
